Clover Health Investments Corp [NASDAQ: CLOV] plunged by -$0.02 during the normal trading session on Tuesday and reaching a high of $3.05 during the day while it closed the day at $2.98.
Clover Health Investments Corp stock has also loss -2.30% of its value over the past 7 days. However, CLOV stock has declined by -19.02% in the 3 months of the year. Over the past six months meanwhile, it has lost -18.13% and gained 104.11% year-on date.
The market cap for CLOV stock reached $1.52 billion, with 388.51 million shares outstanding and 382.28 million shares in the current float. Compared to the average trading volume of 7.85M shares, CLOV reached a trading volume of 5551943 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Clover Health Investments Corp [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $4.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for Clover Health Investments Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 17, 2024. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on October 07, 2024, representing the official price target for Clover Health Investments Corp stock. Previously, the target price had yet another drop from $7 to $3, while Cowen kept a Market Perform rating on CLOV stock.
CLOV stock trade performance evaluation
Clover Health Investments Corp [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.30. With this latest performance, CLOV shares gained by 1.71% in over the last four-week period, additionally sinking by -18.13% over the last 6 months – not to mention a drop of -5.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 50.79, with the RSI for the last a single of trading hit 0.17, and the three-weeks RSI is set at 0.17 for Clover Health Investments Corp [CLOV]. The present Moving Average for the last 50 days of trading for this stock 3.11, while it was recorded at 3.02 for the last single week of trading, and 3.57 for the last 200 days.
Clover Health Investments Corp [CLOV]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp [CLOV] shares currently have an operating margin of -1.64%. Clover Health Investments Corp’s Net Margin is presently recorded at -1.69%.
Return on Equity for this stock declined to -3.88%, with Return on Assets sitting at -3.88%.
Clover Health Investments Corp [CLOV]: Institutional Ownership
There are presently around $26.16%, or 27.22% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 17.35 million shares, which is approximately 3.5581%. RENAISSANCE TECHNOLOGIES LLC, holding 11.27 million shares of the stock with an approximate value of $$13.86 million in CLOV stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $$11.73 million in CLOV stock with ownership which is approximately 1.9568%.
